The prevalence of pre-existing diabetes mellitus in pregnancy (DIP) is about 1% and gestational diabetes (GDM) at 8-30% of pregnancies in Australia. 1,2 DIP and to a lesser extent, GDM are well-known risk factors implicated in a variety of maternal and obstetric complications, including stillbirth and neonatal deaths. The management of diabetes before and during pregnancy is critical in minimising the risk of such complications. The risks of a diabetic pregnancy to a fetus are numerous and include stillbirth, intra-uterine growth restriction (IUGR), large for gestational age (LGA) and macrosomia with associated traumatic birth injuries, congenital abnormalities, intrapartum hypoxia-ischaemia, electrolyte and metabolic abnormalities, and
BackgroundGlycated haemoglobin, or HbA1c, is the main biomarker used to assess long-term glycaemic control in individuals with diabetes, and it correlates with the development of complications.HbA1c: More than just a number Focus | Clinical
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.